Insamo is a startup based in the United States. Brouky records 1 investor associated with the company.
Insamo develops an automated platform that designs, synthesizes, and tests membrane-permeable and orally available cyclic-peptides at scale to discover new drug candidates for challenging diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.